Antiphospholipids Syndrome

A breakthrough in the diagnosis of Antiphospholipids Syndrome from the Diametra.

Diametra has applied for a patent of an innovative Elisa method for the assay of anti-cardiolipin antibodies specific of the Antiphospholipids Syndrome. Such class of antibodies are not detectable by the traditional anti-Cardiolipin methods.

The new discover witnesses the continuous efforts of Diametra in the development of innovative diagnostics, with the purpose to enhance the life quality of the people.

The new kit will be available for sales from October 1st 2010.